AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst

BenzingaJul 22 14:53 ET

Morphic Holding Analyst Ratings

BenzingaJul 22 08:29 ET · Ratings

AnaptysBio Analyst Ratings

BenzingaJul 19 09:00 ET

TSLA-related ETFs Among Top Performing ETFs on a 4-week Performance Base Last Week

Seeking AlphaJul 17 13:38 ET

ORIC Collaborates With Bayer, J&J on Prostate Cancer Study

Seeking AlphaJul 16 17:59 ET

Cantor Fitzgerald Reiterates Overweight on UniQure, Maintains $24 Price Target

BenzingaJul 16 09:13 ET